Thermo Fisher Scientific (TMO) Getting Somewhat Favorable News Coverage, Analysis Shows

Headlines about Thermo Fisher Scientific (NYSE:TMO) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Thermo Fisher Scientific earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave media headlines about the medical research company an impact score of 46.6497949475305 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news stories that may have effected Accern’s analysis:

Shares of Thermo Fisher Scientific (NYSE TMO) traded down $1.29 during trading hours on Friday, reaching $189.88. The company’s stock had a trading volume of 856,644 shares, compared to its average volume of 1,618,454. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific has a fifty-two week low of $140.00 and a fifty-two week high of $201.20. The company has a market cap of $76,658.29, a PE ratio of 32.24, a PEG ratio of 1.75 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the business earned $2.03 EPS. The business’s revenue was up 13.9% on a year-over-year basis. equities research analysts forecast that Thermo Fisher Scientific will post 9.36 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.

A number of equities analysts recently issued reports on the company. Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Leerink Swann increased their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Finally, Cowen reiterated an “outperform” rating and issued a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $205.21.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the transaction, the chief executive officer now directly owns 302,577 shares in the company, valued at approximately $58,016,113.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.49% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific (TMO) Getting Somewhat Favorable News Coverage, Analysis Shows” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit